Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03270098 · ClinicalTrials.gov registry record · NA
Improving Cognition Via Exercise in Schizophrenia
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT03270098 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 104 participants.
The verdict
NCT03270098, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
People with schizophrenia display a broad range of cognitive impairments that have been identified as major determinants of poor functioning and disability. Also, people with schizophrenia are at increased risk for suicide, with approximately 40-50% of individuals attempting to take their own lives during their lifetime. The goal of the proposed study is to examine the impact of remote exercise training on cognition, suicide risk, daily functioning, and biomarkers of cognitive change and suicidality in people with schizophrenia.
Interventions
- BEHAVIORAL Aerobic Exercise
- BEHAVIORAL Stretching and Toning Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2018-04-26 |
| Est. Completion | 2023-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03270098
The ClinicalTrials.gov registry entry for NCT03270098 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aerobic Exercise is the first listed.
NCT03270098 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03270098 about?
NCT03270098 is a clinical study titled "Improving Cognition Via Exercise in Schizophrenia". People with schizophrenia display a broad range of cognitive impairments that have been identified as major determinants of poor functioning and disability. Also, people with schizophrenia are at increased risk for suicide, with approximately 40-50% of individuals attempting to take their own lives ...
What is the current status of trial NCT03270098?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2018-04-26. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT03270098?
The interventions under investigation include: Aerobic Exercise (BEHAVIORAL), Stretching and Toning Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03270098?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.